The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Second primary malignancies (SPM) in newly diagnosed myeloma (MM) patients treated with lenalidomide (Len): Meta-analysis of 6,383 individual patient data (IPD).
Antonio Palumbo
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Millennium; Onyx
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Millennium; Onyx
Sara Bringhen
Honoraria - Celgene; Janssen
Vincent Rajkumar
No relevant relationships to disclose
Giulia Lupparelli
No relevant relationships to disclose
Saad Zafar Usmani
Consultant or Advisory Role - Celgene
Research Funding - Celgene; Millennium; Onyx
Anders Waage
Consultant or Advisory Role - Celgene; Janssen-Cilag; Mundipharma
Honoraria - Celgene; Janssen-Cilag; Mundipharma
Alessandra Larocca
Honoraria - Celgene; Janssen-Cilag
Bronno van der Holt
No relevant relationships to disclose
Pellegrino Musto
Consultant or Advisory Role - Celgene
Honoraria - Celgene
Research Funding - Celgene
Andrea Evangelista
No relevant relationships to disclose
Sonja Zweegman
Honoraria - Celgene; Janssen
Meletios A. Dimopoulos
Honoraria - Celgene; Onyx; Ortho Biotech
Research Funding - Genesis Pharmaceuticals
Roman Hajek
Consultant or Advisory Role - Celgene; Merck
Honoraria - Celgene; Janssen; Merck
Michele Cavo
Consultant or Advisory Role - Celgene; Janssen; Millennium; Novartis
Honoraria - Celgene; Janssen; Novartis
Sagar Lonial
Honoraria - Bristol-Myers Squibb; Celgene; Johnson & Johnson; Millennium; Novartis; Onyx; Sanofi
Giovannino Ciccone
No relevant relationships to disclose
Mario Boccadoro
Consultant or Advisory Role - Celgene; Janssen
Research Funding - Celgene; Janssen
Bart Barlogie
No relevant relationships to disclose
Pieter Sonneveld
Consultant or Advisory Role - Celgene; Janssen; Onyx
Research Funding - Celgene; Janssen; Onyx
Philip L. McCarthy
Consultant or Advisory Role - Celgene; Onyx
Honoraria - Celgene; Janssen; Onyx